Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately
The FDA has categorized this as a Class I recall. If patients update their phone or watch apps as needed, they can continue to use these devices like normal.
Cardiologist sues hospital after he was allegedly let go for sharing safety concerns
The veteran interventional cardiologist claims he was pushed out after repeatedly asking for more coverage from cardiothoracic surgeons in addition to other improvements. The hospital, meanwhile, described the lawsuit as a “collection of false allegations."
Why all heart patients should be vaccinated against the flu, COVID-19, RSV
The American College of Cardiology has shared new recommendations highlighting the protective benefits of a variety of vaccines. The new guidance also examines how to speak with patients who are hesitant to be vaccinated.
Heart surgeons see more potential in AI than colleagues from other fields
Cardiac surgeons see significant value in AI's ability to assist clinicians with administrative tasks and patient selection. When it comes to making clinical decisions, however, there is still a certain amount of skepticism.
New Apple Watch Ultra 3 makes early hypertension detection a priority
"This tool empowers patients and clinicians to work together, putting prevention at the center of care," said Ami B. Bhatt, MD, ACC chief innovation officer. "What we really want to do is create patient agency and reach as many people as we can for earlier detection of high blood pressure."

Viva la France: TAVR procedures soar, mortality rates dip between 2007-2015 in nationwide survey

A country-wide examination of data in France showed a marked increase in transcatheter aortic valve replacement (TAVR) procedures, in addition to reduction in in-hospital mortality for all AVR subsets.

Losing excess weight in childhood decreases diabetes risk

New research in the New England Journal of Medicine April 5 suggests a reduction in body mass index (BMI) before puberty may decrease an individual’s risk of developing diabetes.

Extreme levels of HDL associated with increased risk of infectious disease

Both high and low concentrations of HDL cholesterol are associated with higher risks of infectious disease including gastroenteritis and pneumonia, according to new research published April 7 in the European Heart Journal.

Extreme cold increases mortality, morbidity for those with cardiovascular diseases

Extreme temperatures can put undo pressure on the human body—which can lead to deadly complications for those with cardiovascular and respiratory conditions. Recent research discovered cold temperatures, meaning the first to third percentile of local exposure history, have an especially significant impact on mortality and morbidity for those with cardiovascular diseases.

Exercise is an effective defense for those with genetic risk of CVD

As fitness increases, risk of cardiovascular disease (CVD) may decrease regardless of genetic predisposition, according to new findings published in Circulation on April 9.

Texas nurse charged with murder, accused of causing embolisms in 7 patients

A 34-year-old nurse at a Texas hospital has been charged with murder and accused of introducing stroke-like symptoms in seven patients.

INVOKANA® (canagliflozin) Demonstrated Significant Renal Protective Benefits in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease

AUSTIN, Texas, April 12, 2018 — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced an additional analysis from the landmark CANVAS Program showing INVOKANA® (canagliflozin) improved renal outcomes in people with type 2 diabetes mellitus with or at high risk for cardiovascular disease.

Insurance plans denied coverage for almost 80K claims for cholesterol-lowering drugs

A report issued by the Institute for Patient Access suggests commercial healthcare insurance plans, as well as Medicare, Medicaid and Medicaid managed care, denied coverage for almost 80,000 insurance claims for PCSK9 inhibitors in 2017.

Clinical

Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately

Cardiologist sues hospital after he was allegedly let go for sharing safety concerns

Why all heart patients should be vaccinated against the flu, COVID-19, RSV

Heart surgeons see more potential in AI than colleagues from other fields

New Apple Watch Ultra 3 makes early hypertension detection a priority